Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-28T00:26:50.105Z Has data issue: false hasContentIssue false
  • English
  • Français

Vancomycin-Resistant Bacteria

Published online by Cambridge University Press:  21 June 2016

David M. Shlaes
David M. Shlaes*
Affiliation:
Veterans Affairs Medical Center, Cleveland, Ohio
*
VA Medical Center, 10701 East Blvd., Cleveland, OH 44106
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Infection Control & Hospital Epidemiology , Volume 13 , Issue 4 , April 1992 , pp. 193 - 194
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1992

References

1. Banejee, SN, Emori, TG, Culver, DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 19891989. Am J Med. 1991 suppl B:86S–89S.CrossRefGoogle Scholar
2. Levine, DP, Fromm, BS, Reddy, BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med. 1991;115:674–680.10.7326/0003-4819-115-9-674CrossRefGoogle ScholarPubMed
3. Wenzel, RP, Nettelman, MD, Jones, RN, Pfaller, MA. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med. 1991 suppl B:221S–227S.CrossRefGoogle ScholarPubMed
4. Johnson, AP, Uttley, AHC, Woodford, N, George, RC. Resistance to vancomycin and teicoplanin: an emerging problem. Clin Microbiol Rev. 1990;3:280–291.CrossRefGoogle Scholar
5. Shlaes, DM, Al-Obeid, S, Gutmann, L. Enterococcal resistance to vancomycin and teicoplanin. APUA Newsletter 1989;7:1–4.Google Scholar
6. Shlaes, DM, Etter, L, Gutmann, L. Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin and gentamicin. Antimicrob Agents Chemother. 1991;35:776–779.CrossRefGoogle Scholar
7. Vincent, S, Knight, RG, Green, M, Sahm, DE, Shlaes, DM. Vancomycin susceptibility and identification of motile enterococci. J Clin Microbiol. 1991;29:2335–2337.CrossRefGoogle ScholarPubMed
8. Swenson, JM, Hill, BC, Thornsberry, C. Problems with the disk diffusion test for detection of vancomycin-resistance in enterococci. J Clin Microbiol. 1989;27:2140–2142.CrossRefGoogle ScholarPubMed
9. Karanfil, LV, Murphy, M, Josephson, A, et al. A cluster of vancomycin-resistant Enterococcus fuecium in an intensive care unit. lnfect Control Host Epidemiol. 1992:13:195–200.10.2307/30147097CrossRefGoogle Scholar
10. LeClercq, R, Bingen, E, Su, QH, Lambert-Zechovski, N, Courvalin, P, Duval, J. Effects of combinations of β-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci. Antimicrob Agents Chemother. 1991:35:92–98.CrossRefGoogle ScholarPubMed
11. Unal, S, Flokowitsch, JE, Thomas, LJ, Preston, DA. In vitro synergy between vancomycin and ciprofloxacin against Enterococcus faeculis and Enterococcus fuecium isolates. Presented at the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. September 29-October 2, 1991. Chicago, Ill.Google Scholar